The clustering of malignancies and infections in this case over a short time period supports the hypothesis of immune dysfunction, whilst also emphasising the importance of longitudinal monitoring for patients with FOXN1 mutations, particularly following cytotoxic therapy. This evidence concerns the gene FOXN1 and infection.